Giaj Levra, N.
281  Ergebnisse:
Personensuche X
?
 
?
3

OA06.05 Consensual Definition of Stage III NSCLC Resectabil..:

Dingemans, A.-M. ; Remon, J. ; Hendriks, L....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S57-S58 , 2023
 
?
5

1.5T MR-guided daily-adapted stereotactic body radiotherapy..:

Cuccia, F. ; Rigo, M. ; Figlia, V....
European Urology Open Science.  45 (2022)  - p. S150 , 2022
 
?
6

Toxicity patterns and preliminary clinical outcomes of 1.5T..:

Cuccia, F. ; Figlia, V. ; Rigo, M....
European Urology Open Science.  45 (2022)  - p. S100 , 2022
 
?
7

PO-1773 Feasibility of a novel harmonization method for NSC..:

Botti, A. ; Bertolini, M. ; Trojani, V....
Radiotherapy and Oncology.  170 (2022)  - p. S1578-S1579 , 2022
 
?
9

C2 STEREOTACTIC ABLATIVE RADIOTHERAPY (STAR) IN PATIENTS WI..:

Molon, G ; Costa, A ; Bonapace, S...
European Heart Journal Supplements.  24 (2022)  Supplement_C - p. , 2022
 
?
 
?
11

PO-1256: Feasibility and initial results of Linac-based Ste..:

Giaj Levra, N. ; Niyazi, M. ; Figlia, V....
Radiotherapy and Oncology.  152 (2020)  - p. S661-S662 , 2020
 
?
 
?
 
?
15

OC-0496: Concomitant radiotherapy and TKI in EGFR or ALK po..:

Borghetti, P. ; Bruni, A. ; Bonù, M....
Radiotherapy and Oncology.  127 (2018)  - p. S255-S256 , 2018
 
1-15